Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aung Naing, Kyriakos P. Papadopoulos, Jeffrey R. Infante, Deborah Jean Lee Wong, Karen A. Autio, Patrick Alexander Ott, Gerald Steven Falchook, Manish R. Patel, Shubham Pant, Amita Patnaik, John B Mumm, Melinda Whiteside, Ivan H Chan, Johanna C. Bendell, Todd Michael Bauer, Filip Janku, Rivka R Colen, Nizar M. Tannir, Peter Van Vlasselaer, Martin Oft
Institutions: The University of Texas MD Anderson Cancer Center, South Texas Accelerated Research Therapeutics, Sarah Cannon, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, University of Oklahoma Health Sciences Center, Tennessee Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2487583454